Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2003
12/31/2003WO2004000218A2 Method for making aryl hydrazines and substituted indoles
12/31/2003CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003CA2489375A1 Method for making aryl hydrazines and substituted indoles
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003CA2486958A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
12/30/2003US6670477 Synthesis of enantiomerically enriched 4-piperidinylglycine
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670358 Substituted thioacetamides
12/30/2003CA2198637C Preparation of quaternized glycine nitriles
12/25/2003US20030236368 Preparation of functionalized alkoxyamine initiator and its use
12/25/2003US20030236283 4-Substituted piperidines, and methods of use thereof
12/25/2003US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
12/25/2003US20030236268 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
12/25/2003US20030236266 Anticancer agents; viricides; infection therapy
12/25/2003US20030236262 Dietetics; antidiabetic agents; sexual disorders
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236247 Anticancer agents; autoimmune diseases; antiinflammatory agents
12/25/2003US20030236231 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236225 Substituted ethylene diamines for the treatment of infectious diseases; used for mycobacterial infections, including tuberculosis
12/25/2003US20030236167 Novel herbicides
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/25/2003CA2432964A1 The preparation of functionalized alkoxyamine initiator and its use
12/25/2003CA2432910A1 A process for the synthesis of alkoxyamines and their use in controlled radical polymerization
12/24/2003WO2003106457A1 Spiroindolinepiperidine derivatives
12/24/2003WO2003106421A2 Phenylalkylamines and pyridylalkylamines
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003106390A1 Polymerisation inhibitor
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667319 Neuropeptide Y Y5 receptor antagonists
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003CA2307080C Process for preparing 8-cyclopentyl-6-ethyl-3-¬substituted|-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
12/23/2003CA2059063C Novel antiviral compounds
12/18/2003WO2003104249A1 Novel linker for nucleotides
12/18/2003WO2003104240A1 Process for producing cyclic thioether and synthetic intermediate thereof
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003032072A3 Crosslinkable monomers for novel nonlinear optical polymers
12/18/2003WO2002080857A3 Polymorphs of fexofenadine hydrochloride
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232857 Side effects reduction; for treating nervous system disorders (attention deficit/hyperactivity, and cognitive decline associated with acquired immunodeficiency syndrome)
12/18/2003US20030232837 17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232826 Amidino and guanidino peptidyl compounds
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030230478 Process for the preparation of 1,4 - dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
12/18/2003CA2489255A1 Process for producing cyclic thioether and synthetic intermediate thereof
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1371645A1 Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments
12/17/2003EP1370529A1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003CN1131228C Benzo (5,6) cyclohepta (1,2-6) pyridine derivs. for inhibition of farnesy-protein transferase
12/17/2003CN1131031C Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives for NMDA receptor subtype blockers
12/16/2003US6664418 N-oxyl compounds dissolved in solution with (meth)acrylic acid or one of its esters to prevent polymerization during storage
12/16/2003US6664394 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases
12/16/2003US6664293 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664271 Immunopotentiator agents
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003US6664259 Il-8 receptor antagonists
12/16/2003US6664253 Neurokinin antagonists
12/11/2003WO2003101965A1 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101963A1 Opioid receptor antagonists
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003101381A2 1,2 diamido cycloalkyl sodium channel blockers
12/11/2003WO2003032912A3 Treatment of cns disorders using cns target modulators
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002083071A3 Heterocyclic analgesic compounds and methods of use thereof
12/11/2003WO2002068391A8 Process for resolving racemic mixtures of piperidine derivatives
12/11/2003US20030229121 Antihistamines, antiallergens, skin disorders, antiinflammatory agents
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 380